# OnCo record reliance (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/reliance/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "reliance" ;
  schema:name "RELIANCE"@en ;
  schema:description "The trial that made relma-cel the first CAR-T developed and manufactured in China to be approved, with three quarters of patients responding."@en ;
  schema:url <https://onco.cc/trials/reliance/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/cam4.3686> ;
  onco:status "positive" ;
  onco:tag "china" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/relmacabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/jw-therapeutics/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ying-cancer-med/> .
